FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $476,267 | -16.4% | 100,056 | +0.1% | 0.01% | -25.0% |
| Q1 2023 | $570,023 | -64.8% | 100,004 | -37.8% | 0.01% | -63.6% |
| Q4 2022 | $1,621,645 | -55.0% | 160,718 | 0.0% | 0.02% | -56.0% |
| Q3 2022 | $3,602,000 | -9.6% | 160,718 | 0.0% | 0.05% | -18.0% |
| Q2 2022 | $3,983,000 | -36.1% | 160,718 | 0.0% | 0.06% | -39.6% |
| Q1 2022 | $6,231,000 | -46.5% | 160,718 | -19.3% | 0.10% | -39.5% |
| Q4 2021 | $11,648,000 | +28.5% | 199,076 | +30.2% | 0.17% | +12.8% |
| Q3 2021 | $9,066,000 | -20.3% | 152,957 | +16.7% | 0.15% | -30.2% |
| Q2 2021 | $11,379,000 | +9.2% | 131,106 | +3.8% | 0.21% | -8.2% |
| Q1 2021 | $10,418,000 | – | 126,360 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |